Table 4.
Variable | n | Category | Hazard ratio (95% CI) | p-value |
---|---|---|---|---|
Length of stay | 111 | ≤1 day | 1 | 0.23 |
≥2 days | 1.77 (0.70–4.47) | |||
Time with catheter | 76 | ≤5 days | 1 | |
>5 days | 4.67 (1.75–12.5[0]) | 0.002 | ||
Lasing energy | 116 | – | 1.47* (1.00–2.16) | 0.05 |
Preoperative PSA | 78 | ≤5 | 1 | 0.89 |
>5 | 1.07 (0.42–2.77) | |||
Postoperative PSA | 41 | ≤5 | 1 | 0.77 |
>5 | 1.17 (0.42–3.28) | |||
Preoperative Qmax | 11 | – | 0.56** (0.19–1.64) | 0.29 |
Postoperative Qmax | 18 | – | 0.89** (0.51–1.55) | 0.68 |
CI = confidence interval; PSA = prostate specific antigen; Qmax = maximum flow rate
Hazard ratio for a 50,000J increase in energy
Hazard ratio for a 5-unit increase in Qmax